These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15361404)

  • 21. Rheumatoid factor by laser nephelometry and Waaler-Rose assay: prognostic value in patients with recent-onset rheumatoid arthritis.
    Nikolaisen C; Rekvig OP; Nossent HC
    Scand J Rheumatol; 2005; 34(4):269-76. PubMed ID: 16195159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical role of C-reactive protein in rheumatoid arthritis].
    Nasonov EL; Chichasova NV; Baranov AA; Imametdinova GR; Tishchenko VA; Kuznetsova TB; Nikiforova EL; Ilich-Stoianovich O
    Klin Med (Mosk); 1997; 75(7):26-30. PubMed ID: 9411048
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-tumour necrosis factor {alpha} therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment.
    Naumann L; Huscher D; Detert J; Spengler M; Burmester GR; Buttgereit F
    Ann Rheum Dis; 2009 Dec; 68(12):1934-6. PubMed ID: 19910303
    [No Abstract]   [Full Text] [Related]  

  • 24. Stromal cell-derived factor-1 alpha in rheumatoid arthritis.
    Mittal GA; Joshi VR; Deshpande A
    Rheumatology (Oxford); 2003 Jul; 42(7):915-6. PubMed ID: 12826719
    [No Abstract]   [Full Text] [Related]  

  • 25. Is early remission associated with improved survival or is arthritis persistency associated with increased mortality in early arthritis? Comparisons with the general population.
    van Nies JA; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 Nov; 72(11):e25. PubMed ID: 23852696
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis.
    Hellmann M; Jung N; Owczarczyk K; Hallek M; Rubbert A
    Rheumatology (Oxford); 2008 Jun; 47(6):929-30. PubMed ID: 18411212
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study.
    Brulhart L; Ciurea A; Finckh A; Notter A; Waldburger JM; Kyburz D; Gabay C
    Ann Rheum Dis; 2006 Sep; 65(9):1255-7. PubMed ID: 16540545
    [No Abstract]   [Full Text] [Related]  

  • 28. Paraneoplastic arthritis may mimic rheumatoid arthritis with symmetrical and upper extremity predilecting presentation.
    Bahat G; Kamali S; Saka B; Erten N; Karan MA; Tascioglu C
    J Clin Rheumatol; 2009 Sep; 15(6):319-20. PubMed ID: 19734744
    [No Abstract]   [Full Text] [Related]  

  • 29. [Rituximab: a new therapeutic arm in refractory rheumatoid arthritis: about one case].
    Abdelmoula LC; Testouri N; Ben Hadj Yahia C; Tekaya R; Ben M'barek R; Chaabouni L; Zouari R
    Tunis Med; 2008 Sep; 86(9):841-2. PubMed ID: 19472790
    [No Abstract]   [Full Text] [Related]  

  • 30. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
    Alarcón GS
    Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
    [No Abstract]   [Full Text] [Related]  

  • 31. Rheumatoid arthritis is the major risk factor for septic arthritis in rheumatological settings.
    Favero M; Schiavon F; Riato L; Carraro V; Punzi L
    Autoimmun Rev; 2008 Oct; 8(1):59-61. PubMed ID: 18706527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Etanercept treatment in adults with established rheumatoid arthritis: 7 years of clinical experience.
    Moreland LW; Weinblatt ME; Keystone EC; Kremer JM; Martin RW; Schiff MH; Whitmore JB; White BW
    J Rheumatol; 2006 May; 33(5):854-61. PubMed ID: 16541481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sparing of age-related macular degeneration in rheumatoid arthritis.
    Gaynes BI
    Neurobiol Aging; 2006 Oct; 27(10):1531-2; discussion 1533-4. PubMed ID: 16310288
    [No Abstract]   [Full Text] [Related]  

  • 34. Which are the determinants of dyslipidemia in rheumatoid arthritis and does socioeconomic status matter in this context?
    Dessein PH; Christian BF; Solomon A
    J Rheumatol; 2009 Jul; 36(7):1357-61. PubMed ID: 19567631
    [No Abstract]   [Full Text] [Related]  

  • 35. Extensive pigmentation secondary to minocycline treatment of rheumatoid arthritis.
    Assad SA; Bernstein EF; Brod B; James WD
    J Rheumatol; 2001 Mar; 28(3):679-82. PubMed ID: 11296985
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of extended treatment with anakinra in patients with rheumatoid arthritis.
    Fleischmann RM; Tesser J; Schiff MH; Schechtman J; Burmester GR; Bennett R; Modafferi D; Zhou L; Bell D; Appleton B
    Ann Rheum Dis; 2006 Aug; 65(8):1006-12. PubMed ID: 16396977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures.
    Wendling D; Balblanc JC; Brousse A; Lohse A; Lehuede G; Garbuio P; Toussirot E; Auge B; Jacques D
    Ann Rheum Dis; 2005 Sep; 64(9):1378-9. PubMed ID: 16100348
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-tumor necrosis factor therapy: 6 year experience of a single center in northern Israel and possible impact of health policy on results.
    Braun-Moscovici Y; Markovits D; Rozin A; Toledano K; Nahir AM; Balbir-Gurman A
    Isr Med Assoc J; 2008 Apr; 10(4):277-81. PubMed ID: 18548981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease.
    Inokuma S; Kono H; Kohno Y; Hiramatsu K; Ito K; Shiratori K; Yamazaki J; Nakayama H; Shoda H; Tanaka Y
    Ann Rheum Dis; 2006 Aug; 65(8):1113-4. PubMed ID: 16837494
    [No Abstract]   [Full Text] [Related]  

  • 40. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
    Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
    J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.